A leading pharmaceutical enterprise sought to modernize its research and early development (R&ED) infrastructure with a customized, data-driven and AI-enabled platform that would facilitate modern clinical trials. It needed new-age infrastructure capable of keeping up with rapidly changing clinical trial requirements.
The company partnered with GEP to achieve this goal. GEP adopted a multi-pronged approach to help the firm identify its needs and select a suitable cutting-edge platform that transformed the R&ED infrastructure.
This case study demonstrates how the strategic partnership enabled the company to speed up drug development, improve patient experience and enhance the operational efficiency of its clinical trials.
It’s a must-read for pharma companies that want to upgrade their R&D and clinical trial infrastructure.
RECOMMENDED
Featured
The Cost-Plus World of Supply Chains: The Macroeconomic and Geopolitical Environment
As geopolitical and macroeconomic concerns increase, this survey-based Economist Impact-GEP report looks at what companies are doing to manage the resultant supply chain challenges.
White Paper
Optimizing Business Outcomes by Investing in Sustainable Supply Chains and Procurement
This GEP-sponsored HBR Analytics Services paper explores how making an organization’s procurement and supply chain efforts greener can drive greater business success.
